Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.
2.
3.

Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.

Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003407. doi: 10.1161/CIRCEP.115.003407.

PMID:
27307517
4.

Anticoagulation and population risk of stroke and death in incident atrial fibrillation: a population-based cohort study.

Yu AY, Malo S, Wilton S, Parkash R, Svenson LW, Hill MD.

CMAJ Open. 2016 Jan 7;4(1):E1-6. doi: 10.9778/cmajo.20150096.

5.

Anticoagulation in Atrial Fibrillation.

Ahmad Y, Yh Lip G.

Arrhythm Electrophysiol Rev. 2012 Sep;1(1):12-6. doi: 10.15420/aer.2012.1.1.12.

6.

Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Chen Y, Zhao Y, Dang G, Ouyang F, Chen X, Zeng J.

Medicine (Baltimore). 2015 Dec;94(52):e2364. doi: 10.1097/MD.0000000000002364. Review.

7.

Adherence to Guidelines for Antithrombotic Therapy in Patients with Atrial Fibrillation According to CHADS2 Score before and after Stroke: A Multicenter Observational Study from Korea.

Kim WJ, Park JM, Kang K, Cho YJ, Hong KS, Lee SJ, Ko Y, Lee KB, Park TH, Lee J, Cha JK, Kim DH, Yu KH, Lee BC, Oh MS, Lee J, Lee J, Jang MS, Han MK, Bae HJ.

J Clin Neurol. 2016 Jan;12(1):34-41. doi: 10.3988/jcn.2016.12.1.34.

8.
9.

Atrial Fibrillation in the Young: A Neurologist's Nightmare.

Aggarwal N, Selvendran S, Raphael CE, Vassiliou V.

Neurol Res Int. 2015;2015:374352. doi: 10.1155/2015/374352. Review.

10.

Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry.

Hsu JC, Chan PS, Tang F, Maddox TM, Marcus GM.

JAMA Intern Med. 2015 Jun;175(6):1062-5. doi: 10.1001/jamainternmed.2015.0920. No abstract available.

11.

Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.

Eckman MH, Wise RE, Naylor K, Arduser L, Lip GY, Kissela B, Flaherty M, Kleindorfer D, Khan F, Schauer DP, Kues J, Costea A.

Curr Med Res Opin. 2015 Apr;31(4):603-14. doi: 10.1185/03007995.2015.1019608.

12.

The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society.

Jung BC, Kim NH, Nam GB, Park HW, On YK, Lee YS, Lim HE, Joung B, Cha TJ, Hwang GS, Oh S, Kim JS.

Korean Circ J. 2015 Jan;45(1):9-19. doi: 10.4070/kcj.2015.45.1.9. Review.

13.

Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.

Hsu JC, Chan PS, Tang F, Maddox TM, Marcus GM.

Am J Med. 2015 Jun;128(6):654.e1-654.e10. doi: 10.1016/j.amjmed.2014.11.035.

14.

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.

Nelson WW, Wang L, Baser O, Damaraju CV, Schein JR.

Int J Clin Pharm. 2015 Feb;37(1):53-9. doi: 10.1007/s11096-014-0038-3.

15.

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA; American Heart Association Stroke Council.; Council on Cardiovascular and Stroke Nursing.; Council on Clinical Cardiology.; Council on Functional Genomics and Translational Biology.; Council on Hypertension..

Stroke. 2014 Dec;45(12):3754-832. doi: 10.1161/STR.0000000000000046.

16.

Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?

Denoël P, Vanderstraeten J, Mols P, Pepersack T.

J Aging Res. 2014;2014:693740. doi: 10.1155/2014/693740.

17.

Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice.

Tanislav C, Milde S, Schwartzkopff S, Sieweke N, Krämer HH, Juenemann M, Misselwitz B, Kaps M.

BMC Neurol. 2014 Sep 30;14:195. doi: 10.1186/s12883-014-0195-y.

18.
19.

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.

Ng KH, Hart RG, Eikelboom JW.

Cardiol Ther. 2013 Dec;2(2):135-49. doi: 10.1007/s40119-013-0019-y.

20.
Items per page

Supplemental Content

Support Center